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Abstract: Maternal mental disorders over pregnancy show a clear influence on child 
development. This review is focused on the possible mechanisms by which maternal mental 
disorders influence fetal development via programming effects. This field is complex since 
mental health symptoms during pregnancy vary in type, timing and severity and maternal 
psychological distress is often accompanied by higher rates of smoking, alcohol use, poor 
diet and lifestyle. Studies are now beginning to examine fetal programming mechanisms, 
originally identified within the DOHaD framework, to examine how maternal mental disorders 
impact fetal development. Such mechanisms include hormonal priming effects such as 
elevated maternal glucocorticoids, alteration of placental function and perfusion, and 
epigenetic mechanisms. To date, mostly high prevalence mental disorders such as depression 
and anxiety have been investigated, but few studies employ diagnostic measures, and there 
is very little research examining the impact of maternal mental disorders such as schizophrenia, 
bipolar disorder, eating disorders and personality disorders on fetal development. The next wave 
of longitudinal studies need to focus on specific hypotheses driven by plausible biological 
mechanisms for fetal programming and follow children for a sufficient period in order to 
examine the early manifestations of developmental vulnerability. Intervention studies can 
then be targeted to altering these mechanisms of intergenerational transmission once identified. 
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1. Introduction 
Maternal mental disorders are known to be a major complication of pregnancy [1] and there is already 
substantial evidence from cohort studies that there are important implictions for child development [2,3]. 
However, the specific mechanisms driving poor child outcomes are not well understood. Since such 
child outcomes are in no way inevitable, it is also important to understand the specific circumstances 
where risk is exacerbated or attenuated [2]. Researchers in mental health sciences are increasingly 
making use of the Developmental Origins of Health and Disease (DOHaD) model to understand how 
maternal mental disorders in pregnancy impact on the intrauterine environment and influence fetal 
development. Identifying the specific features of fetal development which predict child and adolescent 
mental health outcomes will inform perinatal treatment options and very possibly major prevention 
opportunities that can be delivered in pregnancy [4,5]. 
In this paper we focus on several biological processes—hormonal and epigenetic programming, and 
placental functioning—and present evidence from studies indicating their role in the transmission of 
maternal mental health. Here we limit our focus to a brief and selective review of three developmental 
outcomes: fetal growth, child temperament, and child and adolescent mental health. 
2. The Prevalence of Mental Disorders and the Complexity of Exposures in Pregnancy 
Psychiatric symptoms in the perinatal period are diverse, and vary from the mild and transitory 
symptoms of so-called “baby blues” through to postpartum psychotic conditions which are rare and 
affect less than 1% of the population. Of course, many women also bring into pregnancy pre-existing 
psychiatric disorders. Perinatal depressive and anxiety disorders are the most commonly researched 
mental disorders across pregnancy [6,7]. In Australia approximately 16% of women experience depression 
in the postnatal period and 9% in the antenatal period [8] however, other studies suggest that rates of 
depression are higher in pregnancy than in the postpartum period [9]. There is considerable continuity 
of depressive symptoms from pregnancy into the postpartum period, with around 50% of women with 
postnatal depressive symptoms having also experienced depression during their pregnancy [10]. The rate of 
maternal anxiety in the antenatal period is less well researched, with some studies reporting prevalence 
to be approximately 7% [11]. There is a high rate of comorbidity between different antenatal mental 
disorders [12] potentially confounding investigations into the effect of any single mental disorder on 
fetal development. 
There is considerable complexity arising from high co-morbidity across mental disorders in 
pregnancy. There is also a wide range of pregnancy exposures that often co-occur in mothers with mental 
disorders, complicating investigations in fetal development. Women depressed in pregnancy have been 
found to be more likely to smoke cigarettes [13], a factor shown to be associated with reduced birth 
weight and with consistent epigenetic changes in offspring tissue [14,15]. A higher proportion of 
depressed women also use alcohol and illicit substances throughout pregnancy and this is associated 
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with a range of adverse outcomes for the fetus [16]. Maternal alcohol use during pregnancy increases 
the risk of pre-term birth [17], alters the pattern of fetal and childhood growth [18] and in extreme cases 
causes congenital abnormalities [19]. Antenatal maternal cannabis use has also been found to impact on 
aspects of fetal development such as growth restriction and, in high levels of exposure, produces features 
similar to fetal alcohol syndrome [20]. 
Women who are depressed in pregnancy are more likely to use psychotropic medications [13] and 
this adds major complication to research into fetal exposures [21–23]. To date the most comprehensive 
investigations have been undertaken examining antidepressant use in pregnancy however, it is unclear 
whether this is associated with effects on fetal development either in terms of reducing depressive 
symptoms and thereby reducing any negative impact of maternal depression on the fetus, or conversely, 
showing subtle adverse effects on fetal development [24–26]. Given the increasing use of antidepressants 
during pregnancy to treat maternal depression and anxiety [27], the influence of antidepressants on fetal 
development and child outcomes is of particular clinical interest [13,26]. 
Poor maternal nutrition has also been associated with abnormal fetal development. This includes 
effects of iron deficiency, low vitamin D, as well as oxidative stress and chronic inflammation associated 
with poor diet [28,29]. Poor maternal nutrition can result in abnormal growth and development of the 
placenta and impaired transference of nutrients from the maternal placenta to the fetus [30]. Maternal 
body mass index is also a likely influence on fetal development [31], however, to date only four studies have 
examined the interaction between maternal mental health, fetal development and maternal BMI [32]. In 
this context it is surprising that so few studies have examined the likely interactions between psychological 
distress and maternal nutrition or lifestyle factors during pregnancy. These are particularly pertinent 
when considering that dietary and lifestyle enhancement are highly feasible and promising interventions 
which may even preserve optimal fetal development in the context of maternal psychological distress, 
although such approaches require further development and evaluation [33]. 
3. DOHaD and Fetal Adaptation 
From a child development perspective, the DOHaD model challenges and extends the traditional 
psychological framework which usually conceptualises child development as consisting of interactions 
between so-called innate factors and the influence of postnatal “environmental” factors [34]. Postnatal 
factors are often considered to be the child’s social, family, peer or school environment. Instead, the 
DOHaD model proposes that in utero development and possibly even factors prior to conception such 
as the mother’s pre-pregnancy weight, nutritional status or her mental health history can influence 
maternal functioning over pregnancy and in this way can be transmitted to the child during fetal 
development. Although it has its origins in epidemiological studies, one of the hallmarks of DOHaD is 
the strong focus on the mechanisms driving fetal and early postnatal development. The framework 
integrates evolutionary theory, molecular sciences and draws on experimental animal models to test 
causal pathways [5]. The DOHaD framework is therefore an important supplement to existing concepts 
used in developmental psychopathology such as developmental lines of continuity and discontinuity, 
resilience and vulnerability to adverse exposures, moderation of outcomes via genetic factors, cumulative 
and interactive combinations of risk factors and kindling effects across development [33,35]. Although 
beyond the scope of the current paper, a comprehensive theoretical integration of DOHaD concepts into 
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the wider mental health sciences would greatly advance empirical work seeking to understand the earliest 
vulnerabilities for future mental disorders. 
There is a long tradition of speculation that perinatal events could influence an individual’s health 
throughout their life. David Barker’s epidemiological studies in the 1980s began with the discovery of 
geographic associations between infant mortality rates and later mortality due to ischemic heart disease 
in areas of England and Wales [36]. This was followed by the examination of birth weight recorded in 
Hertfordshire in the early 20th century linked to records of mortality rates from ischemic heart disease 
in adulthood. Further studies showed similar associations between birth weight and impaired glucose 
tolerance, type II diabetes and metabolic syndrome. The compelling weight of evidence, replicated across 
numerous cohort studies and data linkage studies, suggested an alternative to genetically or environmentally 
determinist models, and instead that a developmental-evolutionary model of disease was needed. The 
DOHaD model was initially focused on low birth weight which was considered to be a robust marker 
for the health of the intrauterine environment [36] and the so-called Barker hypothesis proposed that the 
quality of the intrauterine environment was a major factor in future health and disease arising from the 
programming effects of maternal pregnancy nutrition [5]. 
The conceptual basis of the DOHaD model draws heavily on a synthesis of both developmental and 
evolutionary concepts [37]. Firstly, the fetus is considered to be developmentally plastic and be capable 
of using a variety of mechanisms to adapt to its intrauterine environment [5]. Developmental plasticity 
is an evolved trait, but developmentally, it is likely the degree of plasticity will vary across the life course. 
In species like humans, with long and complex life histories, early fetal and neonatal development is likely 
to be a period where the developing organism is open to environmental information while later childhood 
may be a period of being less open to environmental information [38]. Further, developmental plasticity 
is expected to vary according to the nature of the environmental input. Namely, the capacity of the 
organism to alter its developmental course is most likely to be highest for inputs which are evolutionarily 
predictable. So it follows that developmental plasticity should be high to exposures such as stress, 
variation in nutrition and effects of parity. However, novel exposures (from an evolutionary perspective) 
such as neurotoxic exposures to smoking or even early weaning would be predicted to induce greater 
physiological effect and alter the developmental pathway to a greater degree since fetal response is likely 
to be less adaptive. For example, in a nutritionally sparse environment, the fetus shows remarkable 
developmental plasticity in being able to preserve brain and heart vasculature at the expense of other 
organ growth. However, in response to exposure to maternal smoking and even second hand smoke from 
paternal smoking, fetal growth is significantly compromised and there are long lasting developmental 
impacts [39]. 
Another feature of the DOHaD model of development is the idea imported from Life History Theory 
that there are two forms of adaptation: immediate adaption to environmental demands and a mode of 
predictive adaptation to expected future environments. Development has a forecasting aspect whereby 
an organism is seeking to predict the kind of environment it is likely to encounter in its future.  
Fetal development is seeking to optimize not merely survival but also the more general goal of 
reproductive fitness and comes to the fore particularly during the pubertal transition. However, once in 
train, the developmental life course cannot easily be reversed. What may be adaptive changes of the fetal 
endocrine-metabolic systems in utero, may predispose the adolescent or adult to vulnerability to 
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biological or psychosocial challenges. The onset of Common Mental Disorders such as depression and 
anxiety provide some of the most compelling examples of this process as we outline below. 
4. Hormonal Programming 
Programming refers to the influence of specific exposures that trigger biological processes operating 
during critical periods in early life, which in turn produce stable and long term alterations in the organism’s 
developmental pathway [38]. Within a health and medical context, the concept of programming has been 
proposed to provide an explanatory framework for understanding observed associations between 
environmental exposures in early development and later disease, or psychiatric disorders in the mature 
organism. Thus, programming effects refer to the specific influence of a specific factor during a well-defined 
developmental period as it influences the organization of target tissues or gene-expression patterns that, 
in turn, influence the course of development and functioning across the life course. 
Cortisol provides a good example of hormonal imprinting where exposure of the fetus to maternal 
cortisol during fetal development may impact on the responsivity of neuroendocrine systems related to 
stress and psychopathology in later development. Specifically, HPA-axis reactivity can be altered over 
the long term either in terms of baseline levels, diurnal patterns or degree of response to acute stress. 
The exact mechanisms involved are complex but the effect might occur in relation to establishing the 
density of hormone receptor sites such as the glucorticoid receptor in target brain regions such as the 
hypothalamus or hippocampus. Variation in HPA activity may be due to changes in the activity or 
concentration of glucocorticoids or it may be due to alteration in glucocorticoid receptor density in target 
tissues or even to alteration in cortisol metabolism [40]. Variation in the density of receptor sites is likely 
to have long-term functional implications. An example here is work done largely in rodent models 
showing that stressful early life exposures induces differences in the degree of methylation in glucocorticoid 
receptors in the hypothalamus with functional impacts on later stress related behaviour [41]. 
Also in animal studies, the phenomenon of maternal prenatal priming of postnatal maternal behaviour 
offers a further example of hormonal programming. In normal development, increases in oestrogen over 
pregnancy prime oxytocin receptors in the limbic system, reducing maternal fear of novel stimuli and 
increasing the mother’s receptivity to the otherwise novel social signals coming from the infant. In turn, 
post-natally these infant signals and behaviour such as nursing trigger additional maternal affective and 
motivational systems, underpinned by endocrine changes, resulting in sustained parental investment. 
This particular model has yet to be fully tested in humans although there are a number of promising 
studies (See review by Galbally et al. [42]). 
5. Epigenetic Programming 
Epigenetic factors are non-genetic factors which regulate genomic activity across development and 
are also known to operate across generations as a non-genomic mode of inheritence. Epigenetic 
processes do not change the DNA nucleotide sequence but can modify the pattern of transcription of 
genes in a tissue or cell specific manner [43]. This includes DNA methylation and the acetylation and 
methylation of histones that influence chromatin structures [44]. Changes in these epigenetic markers have 
been shown to be associated with exposures such as stress, depression, diet, obesity, smoking and postnatal 
caregiving although in many cases the direction of causality has yet to be established. Both DNA 
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methylation and histone modification play a fundamental role in differentiation of cell structure and function 
during embryogenesis and fetal development. As such, epigenetic studies of early development have 
become a cornerstone of DOHaD research and offer great promise of pointing towards key biological 
mechanisms following deleterious exposures and driving poor child health and mental health outcomes. 
Emerging evidence suggests that epigenetic programming continues with significant dynamism across 
early postnatal life but it is generally accepted that the methylation status of many genes is established 
in very early development. Altered epigenetic profiles may mediate links between specific intrauterine 
and early postnatal exposures and future mental health outcomes [38]. As noted by Meaney the recent 
discovery of the extent to which environmental signals can remodel epigenetic markers represents a major 
conceptual shift in the understanding of environmental influence on gene expression and function [41]. 
However, this science is in its early days and there remain major questions in the epigenetic field. 
These include the developmental periods of greatest susceptibility to modification, how genetic variation 
may affect epigenetic modifications, the relative stability of methylation in functional sites and which 
cell types are most closely related in their epigenetic profiles. Above all, clinicians are interested in 
whether environmentally induced epigenetic changes can be reversed with early interventions. 
A good example of epigenetic influences on fetal development is the case of maternal smoking during 
pregnancy. While there is plenty of evidence that maternal smoking and even second hand smoke 
exposure in pregnancy has a range of negative effects on fetal and later child development, epigenetic 
studies have pointed to a very specific marker of such exposure in the child’s epigenome. There is now 
consistent evidence of epigenetic modifications consistently associated with the offspring of maternal 
smokers with several studies now reporting hypomethylation of the AHRR gene in neonatal blood [15]. 
There is also preliminary evidence that these epigenetic changes due to fetal exposure to maternal 
smoking may even transmit to the grandchild generation. 
There are a wide range of pregnancy exposures that often co-occur and complicate investigations of 
any single exposure on fetal and then child development. As mentioned above, smoking in pregnancy is 
linked to depressive symptoms, more frequent use of psychotropic medications and other prescribed 
medications, [13] poor maternal nutrition, iron deficiency and low vitamin D [29]. Carefully designed 
epigenetic studies may well reveal that each of these exposures is associated with a specific epigenetic 
biomarker during fetal development and, in turn, these markers may predict future disease and disorder. 
6. Placental Programming 
The placenta serves as an interface between maternal and fetal physiology and functions as a 
temporary endocrine structure, which regulates the transfer of nutrients to the fetus and protects it from 
the growth-inhibiting effects of maternal glucocorticoids. There is increasing interest in the role placental 
biology might play in the interface between maternal antenatal distress and fetal development. 
One area of focus has been fetal exposure to glucocorticoids, be they of maternal, placental or fetal 
adrenal origin. The availability of cortisol to the fetus is regulated by the 11-HSD isozymes. This enzyme 
is highly expressed in the placenta and the 11-HSD2 form inactivates maternal cortisol during its 
passage into the fetal blood stream. Decreases in placental 11-HSD2 would be expected to increase the 
fetal circulation of glucocorticoid with a range of impacts on fetal development including restriction of 
fetal growth and particularly head growth, fetal HPA axis development and the hormonal programming of 
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neuroendocrine aspects of the stress response. These aspects of fetal development may well have long-term 
implications for vulnerability to a range of cognitive and emotional disorders, particularly depressive, anxiety 
and attention related mental health conditions. In this way the expression level of 11-HSD2 in the placenta 
directly influences the exposure of the fetus to circulating maternal stress hormones. Evidence that maternal 
depression or high stress during the antenatal period can lead to a down-regulation of 11-HSD2 suggests 
that it may be a key regulator of infant growth, development and stress response playing a potentially 
critical role in the formative stages of the fetal HPA-axis. Animal studies have shown a link between 
maternal stress and placenta 11-HSD2 activity and a small number of recent findings indicate that there 
may be a similar pattern evident in humans [45] although further work is required. 
7. Maternal Mental Health and Fetal Programming 
Maternal psychological distress is accompanied by metabolic and functional changes that may also 
influence fetal development. These include autonomic changes, disturbance of maternal circadian rhythms, 
and behavioral changes that may influence maternal diet and lifestyle. Such physiological changes may 
influence the availability of oxygen and glucose to the fetus, disrupt maternal and placental endocrine 
functions, induce fetal oxidative stress, or reduce fetal circulation of insulin like growth factors (IGF I 
and IGF II) which directly regulate fetal development and growth [46]. As Barker (1997) [47] has 
argued, fetal adversity, even for a short period can slow and alter the patterns of rapid cell division in 
fetal development, either as a direct effect of under-nutrition or via changes in the function of growth 
factors or hormones. Neural development can similarly be impacted, affecting not only cell density and 
function but the developing connectivity across neural regions [48]. It is possible that these processes 
result in not only intrauterine growth restriction or preterm birth, but in long lasting effects on mental 
health via fetal HPA axis programming [30]. There are a variety of mechanisms by which maternal 
mental disorders may impact on fetal development. In most, but not all studies, maternal psychological 
distress is associated with elevated maternal stress hormones such as cortisol, adrenocorticotropic 
hormone (ACTH) and adrenaline [49]. 
Alternations in maternal levels of these hormones may be transferred to the fetus via the placenta [50]. 
However, it is known that maternal circulation of glucocorticoids naturally increases across pregnancy [51] 
and the placenta may have adaptive mechanisms designed to protect the fetus from these maternal 
changes (as mentioned in the previous section). One study has found that corticotropin-releasing 
hormone levels (CRH) in mid-pregnancy are associated with prenatal, but not postnatal depression but 
overall the literature on maternal mental health and CRH in pregnancy shows mixed findings. In short, 
any transmission of maternal mental state during pregnancy must be traced to alterations in maternal 
physiology, and via the placenta which may moderate, adapt to, or exacerbate maternal conditions, onto 
the fetus [52]. It is also likely that the developing fetus exerts an influence on maternal mental state, 
equally via placental passage. 
8. Child Outcomes following Maternal Mental Disorder in Pregnancy 
Traditionally one of the key motivations in perinatal mental health for addressing maternal depression 
and anxiety was not only to address the mother’s psychiatric disorder but to also improve the quality of 
the parent-child relationship. However, The DOHaD model draws attention to the role of antenatal 
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mental health and the findings emerging from fetal programming research that suggest that the basic 
platform for the child’s future stress biology is probably being established during the intrauterine period. 
The DOHaD model implies that prevention interventions ought to be focused on preconception and 
pregnancy mental health and exposure of mothers to acute or chronic stressors over pregnancy. Early 
exposure of offspring to maternal anxiety and depression has been associated with vulnerability to 
behavioural and emotional problems during childhood and adolescence [33]. Maternal stress experienced 
during pregnancy is associated with pre-term delivery [53], later symptoms of ADHD and delayed 
language development during childhood in several studies. Maternal prenatal cortisol concentrations have 
been examined extensively as a predictor of child developmental outcomes and these associations have 
been confirmed in several studies but remain obscured by considerable variation in measurement and 
design. A recent systematic review suggested critical gestational periods for maternal cortisol and that the 
underlying mechanisms may be more complex than simply cortisol levels [54]. 
In this paper, we focus on three major child outcomes that have been examined in numerous studies 
to date. The selection of fetal growth, temperament and child mental health is based on the clinical and 
public health importance of these child developmental outcomes. Robust evidence suggesting an 
influence on such outcomes from fetal programming mechanisms will have important intervention 
consequences. Above all, such findings imply that interventions for maternal mental health in pregnancy 
also need to consider the impact of such conditions of fetal development. Furthermore, effective interventions 
for both mother and fetus during pregnancy can be considered important prevention interventions for 
future child development. 
In order to select papers of interest we searched Web of Science, Embase, and Scopus Databases, 
from inception to July 2015, for cohort studies assessing the effects of maternal mental health in 
pregnancy on the child developmental outcomes of interest. Since the intention was not to conduct a 
comprehensive systematic review of each outcome, but to provide an overview of recent studies, we were 
highly selective and focused on studies based on overall study quality and relevance. 
8.1 Fetal Growth Findings 
Fetal growth is a complex process that is regulated by a variety of factors including maternal and fetal 
genetics, maternal health and nutrition that determines nutrient and oxygen availability to the fetus, 
maternal endocrine systems and the functioning of the utero-placental system [46,55]. In the majority of 
epidemiological studies exploring the DOHaD hypothesis, birth size has been used as a proxy for the 
quality of the intrauterine environment. A number of reviews have already reported consistent associations 
between exposure to antenatal depression and anxiety and reduced birth size with implications for the 
growth rate over childhood [6,56]. 
However, birth size is not an ideal proxy for fetal development since variation of growth within 
pregnancy is not captured [33,57] and there are several distinct patterns of fetal growth restriction that 
impact on different parameters of growth. With the advent of routine ultrasound biometry, studies are able 
to examine fetal growth as a function of maternal mental disorders in pregnancy. To date, nine studies 
have examined different aspects of the influence of maternal depression, anxiety and stress on fetal 
growth [32]. Maternal mental health problems experienced during pregnancy have been found to be 
associated with a variety of adverse fetal growth outcomes including decreased abdominal growth [58], 
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slower fetal weight gain [58–60] and reduced fetal head circumference growth [58,59]. Of particular 
interest are studies that performed multivariate analyses showing that, amongst mental heath symptoms, 
maternal anxiety is a consistently strong predictor of reductions in fetal head growth. Emerging research 
also suggests that maternal neuroendocrine function measured via cortisol levels may be a factor 
mediating the relationship between maternal mental health and fetal development [60–62]. However, it 
is important to place these findings in the context of other deleterious exposures during pregnancy and 
consider the clinical significance of these exposures for child development. For example, one large study 
from the Netherlands suggested that the impact of maternal mental health on fetal growth was less than 
one third that of maternal smoking during pregnancy [59]. 
A further possible mediating factor between depression, anxiety and fetal growth may be antidepressant 
exposure, with one study reporting reduced fetal head growth was being associated with SSRI exposure [59]. 
This study reported that whilst SSRI exposure did reduce depressive symptoms over pregnancy, fetuses 
exposed to SSRIs also had reduced head growth when compared to the non-medicated groups. The findings 
are particularly important clinically given that some researchers have suggested that antidepressants may 
actually protect fetal development from the effects of untreated antenatal depression. Appropriate prescription 
practices during pregnancy remains a topic of lively debate and require further investigation [23,63]. 
8.2. Temperament 
One of the most compelling areas of investigation is the influence of maternal mental health in 
pregnancy on child temperament. Temperament is considered to reflect individual differences in the regulation 
of experience and emotions which emerges early in life and remain moderately stable across 
development [64]. Temperament is distinct from character which develops in a stepwise manner over the life 
course, progressively assimilating higher-order cognitive capacities, and experience-dependent social and 
cultural learning, leading to increasingly sophisticated representations of the self over time. Temperament is 
generally considered to be a highly heritable platform for social and emotional development while conceding 
that temperament remains open to interaction with the environmental influence across development. As 
such, the integration of a DOHaD model into studies of the ontogeny of temperament is of great interest. 
Several studies have indicated that the infants of mothers with elevated cortisol levels in pregnancy 
showed increased fussiness and negative behaviour [65]. In a 2007 study by Davis and colleagues 
mothers who experienced higher late pregnancy cortisol levels reported their infants to show higher 
levels of negative reactivity. Notably this association remained after controlling for postpartum depression. 
Such reports of temperament however are typically based on maternal self-report and so such studies 
suffer from the potential for bias due to common measurement methods from common informants. So 
too, it is known that maternal characteristics such as personality and mood can influence maternal ratings 
of child behaviour [66–69]. Nonetheless, greater crying, fussing and negative facial expressions in 
infants of mothers with higher prenatal cortisol levels have also been identified via behavioural 
observations made by investigators blinded to maternal prenatal variables. 
8.3. Child Mental Health 
Several large cohort studies have examined maternal anxiety and depression in pregnancy to 
demonstrate prospective prediction of child mental health outcomes. Loomans et al. [70] examined 
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prenatal state anxiety and child outcomes at five years in a sample of over 3000 mothers from 
Amsterdam. Maternal state anxiety measured at 16 weeks gestation was significantly associated with an 
increased likelihood of inattention/hyperactivity problems for boys (OR = 2.39) but was not significant 
for girls. In a similar vein, analyses conducted in the Avon Longitudinal Study of Parents and Children [71] 
study by Connor et al. [71,72] in over 7000 mother-child pairs found that prenatal maternal anxiety at 
32 weeks was a significant predictor of inattention/hyperactivity symptoms in boys. Clavarino et al. [73] 
examined a sample of close to 4000 and found prenatal maternal anxiety was associated with a moderate 
increase in risk of attention problems at five that remitted in adolescence and a three-fold increase in risk 
of anxiety problems that persisted into adolescence. Robinson et al. [74] reported data from the Western 
Australian Pregnancy Cohort (Raine) Study suggesting that pregnancy experiences of major life 
stressors were associated with an increased likelihood of both emotional and behavioral problems at five 
years of age. 
Very little research has employed the DOHaD framework to examine the child mental health 
outcomes of pregnant women with severe mental disorders such as bipolar disorder, psychoses, 
personality disorders, and eating disorders [2]. In an effort to examine the heritability of schizophrenia, 
there is body of literature following the offspring of pregnant women with schizophrenia, generally 
indicating that 15% to 40% of children whose parents have schizophrenia develop a psychotic disorder 
in adulthood [75]. However, much of this work predates the findings on fetal programming mechanisms 
discussed in this review. In terms of personality disorders, a recent study of a small sample of women 
diagnosed with Borderline Personality Disorder found high rates of exposure to illicit substances and 
that a very high proportion of children were referred to child protection services. Women with Borderline 
Personality Disorder also anticipated the birth of their child as traumatic and frequently requested early 
delivery. As compared to unaffected infants, the infants born to mothers with Borderline Personality 
Disorder were significantly more likely to have negative birth outcomes such as lowered Apgar scores, 
prematurity and to be admitted to a special care nursery [76]. 
9. Conclusions 
The current review has found that there is a consistent body of research that suggests that maternal 
psychological distress, measured mostly as symptoms of depression, anxiety and stress, is a significant 
factor to be considered in fetal development. Since stress and nutrition are closely interrelated, this 
suggests that there may be common mechanisms involved. Alteration in stress hormones and changes in 
specific key nutrients during critical developmental periods may act synergistically to program fetal 
neurodevelopment [77]. 
Additional studies with prospective, repeated measure designs that incorporate analysis of known 
covariates are required to investigate the complex relationship between maternal mental health in 
pregnancy and fetal development. The field will also be advanced by studies that include measures of 
the biological mechanisms of this transmission and current investigations of hormonal, epigenetic and 
placental function are encouraging. Further studies are also needed to further extend this area of research 
into other forms of maternal psychopathology such as psychotic, bipolar, personality and eating 
disorders. Efforts to address mental disorders in pregnancy are significant not only in addressing the 
Healthcare 2015, 3 1222 
 
mother’s wellbeing but increasingly can be understood as a major preventative intervention targeting 
intrauterine development. 
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